Ritanserin counteracts both rat vacuous chewing movements and nigro-striatal tyrosine hydroxylase-immunostaining alterations induced by haloperidol

Attenuation of haloperidol‐induced catalepsy by a 5‐HT_2C receptor antagonist

C. Reavill, Anthony J. Kettle, Vicky Holland et al. · British Journal of Pharmacology · 1999 · 132 citations · Full text

Medicine, Neuroscience, Pharmacology +16

MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.

Hans Rollema, M Skolnik, Jan C. d’Engelbronner et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 123 citations

Medicine, Neurobiology, Pharmacology +15

A study of the mechanisms involved in the neurotoxic action of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain

M. Isabel Colado, Jorge Camarero, Annis O. Mechan et al. · British Journal of Pharmacology · 2001 · 122 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Commentary on "Clinical studies on the mechanism of action of clozapine; the dopamine–serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18–S27

Herbert Y. Meltzer · Psychopharmacology · 2002 · 108 citations

Medicine, Pharmacology, Psychiatry +16

1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies.

Jeffrey R. Bloomquist, E. King, Alesia M Wright et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 67 citations

Life Sciences, Neuroscience, Pharmacology +17